171 related articles for article (PubMed ID: 36612108)
1. Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions.
Kaur K; Jewett A
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612108
[TBL] [Abstract][Full Text] [Related]
2. Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice.
Kaur K; Kozlowska AK; Topchyan P; Ko MW; Ohanian N; Chiang J; Cook J; Maung PO; Park SH; Cacalano N; Fang C; Jewett A
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878338
[No Abstract] [Full Text] [Related]
3. Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors
Kaur K; Topchyan P; Kozlowska AK; Ohanian N; Chiang J; Maung PO; Park SH; Ko MW; Fang C; Nishimura I; Jewett A
Oncoimmunology; 2018; 7(5):e1426518. PubMed ID: 29721395
[TBL] [Abstract][Full Text] [Related]
4. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.
Jewett A; Kos J; Fong Y; Ko MW; Safaei T; Perišić Nanut M; Kaur K
Semin Cancer Biol; 2018 Dec; 53():178-188. PubMed ID: 30081230
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice.
Kaur K; Chang HH; Cook J; Eibl G; Jewett A
Front Immunol; 2017; 8():1606. PubMed ID: 29255459
[TBL] [Abstract][Full Text] [Related]
7. Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice.
Kaur K; Chen PC; Ko MW; Mei A; Senjor E; Malarkannan S; Kos J; Jewett A
Front Immunol; 2023; 14():1132807. PubMed ID: 37197660
[TBL] [Abstract][Full Text] [Related]
8. Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.
Kaur K; Jewett A
Cells; 2024 Jan; 13(3):. PubMed ID: 38334605
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ.
Kaur K; Sun Y; Kanayama K; Morinaga K; Hokugo A; Nishimura I; Jewett A
Front Endocrinol (Lausanne); 2023; 14():1111627. PubMed ID: 36742414
[TBL] [Abstract][Full Text] [Related]
10. Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.
Kaur K; Cook J; Park SH; Topchyan P; Kozlowska A; Ohanian N; Fang C; Nishimura I; Jewett A
Front Immunol; 2017; 8():297. PubMed ID: 28424683
[TBL] [Abstract][Full Text] [Related]
11. Enhanced development of functional human NK cells in NOD-scid-IL2rg
Aryee KE; Burzenski LM; Yao LC; Keck JG; Greiner DL; Shultz LD; Brehm MA
FASEB J; 2022 Sep; 36(9):e22476. PubMed ID: 35959876
[TBL] [Abstract][Full Text] [Related]
12. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
[TBL] [Abstract][Full Text] [Related]
13. Improved B cell development in humanized NOD
Jangalwe S; Shultz LD; Mathew A; Brehm MA
Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
[TBL] [Abstract][Full Text] [Related]
14. Similarities and Differences between Osteoclast-Mediated Functional Activation of NK, CD3+ T, and γδ T Cells from Humans, Humanized-BLT Mice, and WT Mice.
Kaur K; Jewett A
Crit Rev Immunol; 2024; 44(2):61-75. PubMed ID: 38305337
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells.
Kaur K; Ko MW; Ohanian N; Cook J; Jewett A
Sci Rep; 2020 Nov; 10(1):20363. PubMed ID: 33230147
[TBL] [Abstract][Full Text] [Related]
16. Engrafted human cells generate adaptive immune responses to Mycobacterium bovis BCG infection in humanized mice.
Lee J; Brehm MA; Greiner D; Shultz LD; Kornfeld H
BMC Immunol; 2013 Dec; 14():53. PubMed ID: 24313934
[TBL] [Abstract][Full Text] [Related]
17. Supercharged NK Cell-Based Immuotherapy in Humanized Bone Marrow Liver and Thymus (Hu-BLT) Mice Model of Oral, Pancreatic, Glioblastoma, Hepatic, Melanoma and Ovarian Cancers.
Kaur K; Jewett A
Crit Rev Immunol; 2023; 43(2):13-25. PubMed ID: 37938193
[TBL] [Abstract][Full Text] [Related]
18. Novel strategies to target cancer stem cells by NK cells; studies in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Front Biosci (Landmark Ed); 2017 Jan; 22(2):370-384. PubMed ID: 27814619
[TBL] [Abstract][Full Text] [Related]
19. ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor.
Kaur K; Safaie T; Ko MW; Wang Y; Jewett A
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440654
[TBL] [Abstract][Full Text] [Related]
20. Sarcoma IL-12 overexpression facilitates NK cell immunomodulation.
Rademacher MJ; Cruz A; Faber M; Oldham RAA; Wang D; Medin JA; Schloemer NJ
Sci Rep; 2021 Apr; 11(1):8321. PubMed ID: 33859303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
